AMYT logo

Amryt Pharma (AMYT)

Profile

Full Name

Amryt Pharma plc

Ticker Symbol

AMYT

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Ireland

IPO

July 8, 2020

Indexes

Not included

Website

http://www.amrytpharma.com

Employees

289

Key Details

Price

-

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$222.54M(+21.87% YoY)

Annual EPS

$0.02(+100.61% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    -
    AMYT price value is unknown

    30-Day Relative Volume

    -
    AMYT 30-day relative volume value is unknown

    Price Performance

    Price Most recent change

    -
    AMYT price change on Jan 1, 1 is unknown

    Price YTD change

    -
    AMYT price ytd change is unknown

    Price 1-year change

    -
    AMYT price 1-year change is unknown

    Price 3-year change

    -
    AMYT price 3-year change is unknown

    Price Range

    Price All-time high

    $14.70
    AMYT price is currently at an all-time high

    Price 3-year low

    $14.70
    AMYT price is currently at its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    -
    AMYT market capitalization value is unknown

    Market cap 3-year change

    -
    AMYT market capitalization 3-year change is unknown

    Market cap All-time high

    $936.28M
    AMYT market capitalization is currently at an all-time high

    Market cap sector rank

    -
    AMYT market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    AMYT {parameterFullLabel} has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    -0.7%
    AMYT shares outstanding is down -0.7% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -
    AMYT beta value is unknown

    200-day SMA

    -
    AMYT SMA 200 is unknown

    50-day SMA

    -
    AMYT SMA 50 is unknown

    RSI

    -
    AMYT 14-day relative strength index value is unknown

    Volume

    -
    AMYT 30-day relative volume value is unknown

    ATR

    -
    AMYT average true range value is unknown

    10-day Historical Volatility

    -
    AMYT 10-day historical volatility value is unknown

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $222.54M
    AMYT annual revenue is $222.54 million

    Revenue Analysts estimate

    $265.67M
    AMYT annual revenue is currently -16.23% lower than the consensus analysts' forecast

    Revenue 1-year change

    +21.87%
    AMYT annual revenue is up +21.87% year-on-year

    Revenue Sector rank

    -
    AMYT annual revenue is unknown

    EPS

    EPS

    $0.02
    AMYT annual earnings per share is $0.02

    EPS Analysts estimate

    -
    AMYT annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +100.61%
    AMYT annual earnings per share is up +100.61% year-on-year

    EPS Sector rank

    -
    AMYT annual earnings per share is unknown

    Profit

    Gross profit

    $116.42M
    AMYT annual gross profit is $116.42 million

    Gross margin

    52.32%
    AMYT annual gross profit margin is 52.32%

    Operating profit

    -$21.64M
    AMYT annual operating income is -$21.64 million

    Operating margin

    -9.72%
    AMYT annual operating profit margin is -9.72%

    Net income

    $1.00M
    AMYT annual net profit is $1.00 million

    Net margin

    0.45%
    AMYT annual net profit margin is 0.45%

    Expenses

    Total expenses

    $244.18M
    AMYT annual total expenses is $244.18 million

    Operating expenses

    $138.06M
    AMYT annual total operating expenses is $138.06 million

    Cost of goods sold

    $106.12M
    AMYT annual cost of goods sold is $106.12 million

    Selling, general & administrative expenses

    $100.34M
    AMYT annual SGA is $100.34 million

    Depreciation and amortization

    $50.74M
    AMYT annual depreciation & amortization is $50.74 million

    Interest expense

    $23.46M
    AMYT annual interest expense is $23.46 million

    Income tax

    -$7.56M
    AMYT annual income tax is -$7.56 million

    EBIT & EBITDA

    EBIT

    $16.90M
    AMYT annual earnings before interest & taxes is $16.90 million

    EBITDA

    $67.64M
    AMYT annual EBITDA is $67.64 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $816.06M
    AMYT annual total assets is $816.06 million

    Non current assets

    $533.35M
    AMYT annual long term assets is $533.35 million

    Current assets

    $282.71M
    AMYT annual total current assets is $282.71 million

    Cash and cash equivalents

    $112.77M
    AMYT annual cash & cash equivalents is $112.77 million

    Accounts receivable

    $34.26M
    AMYT annual accounts receivable is $34.26 million

    Inventory

    $115.77M
    AMYT annual inventory is $115.77 million

    Liabilities

    Total liabilities

    $459.40M
    AMYT annual total liabilities is $459.40 million

    Long term liabilities

    $302.12M
    AMYT annual total long term liabilities is $302.12 million

    Current liabilities

    $157.28M
    AMYT annual total current liabilities is $157.28 million

    Accounts payable

    $41.06M
    AMYT annual accounts payable is $41.06 million

    Debt

    Total debt

    $199.18M
    AMYT annual total debt is $199.18 million

    Total debt 1-year change

    +5.73%
    AMYT annual total debt is up +5.73% year-on-year

    Long term debt

    $199.18M
    AMYT annual long term debt is $199.18 million

    Short term debt

    -
    AMYT annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $356.66M
    AMYT annual stockholders equity is $356.66 million

    Book value

    $356.66M
    AMYT annual book value is $356.66 million

    Retained earnings

    -$233.29M
    AMYT annual retained earnings is -$233.29 million

    Working capital

    $125.43M
    AMYT annual working capital is $125.43 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $15.54M
    AMYT annual cash flow from operations is $15.54 million

    Cash from operations 1-year change

    -42.21%
    AMYT annual cash flow from operations is down -42.21% year-on-year

    Cash from investing

    $106.40M
    AMYT annual cash flow from investing activities is $106.40 million

    Cash from investing 1-year change

    +4572.55%
    AMYT annual cash flow from investing activities is up +4572.55% year-on-year

    Cash from financing

    -$125.43M
    AMYT annual cash flow from financing activities is -$125.43 million

    Cash from financing 1-year change

    -581.89%
    AMYT annual cash flow from financing activities is down -581.89% year-on-year

    CAPEX

    CAPEX

    $1.54M
    AMYT annual capital expenditures is $1.54 million

    CAPEX 1-year change

    -37.35%
    AMYT annual capital expenditures is down -37.35% year-on-year

    Free Cash Flow

    Free cash flow

    $13.99M
    AMYT annual free cash flow is $13.99 million

    Free cash flow 1-year change

    -42.7%
    AMYT annual free cash flow is down -42.7% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    52.32%
    AMYT annual gross profit margin is 52.32%

    Operating margin

    -9.72%
    AMYT annual operating profit margin is -9.72%

    Net margin

    0.45%
    AMYT annual net profit margin is 0.45%

    ROA & ROE

    ROA

    0.15%
    AMYT annual return on assets is 0.15%

    ROE

    0.47%
    AMYT annual return on equity is 0.47%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AMYT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AMYT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -
    AMYT price to book ratio value is unknown

    PB ratio Sector rank

    -
    AMYT price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    AMYT price to sales ratio value is unknown

    PS ratio Sector rank

    -
    AMYT price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    AMYT enterprise value value is unknown

    Enterprise value Sector rank

    -
    AMYT enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    AMYT EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    AMYT EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.80
    AMYT annual current ratio is 1.80

    Quick ratio

    1.06
    AMYT annual quick ratio is 1.06

    Leverage

    Debt to equity

    0.56
    AMYT annual debt to equity ratio is 0.56

    Interest coverage ratio

    0.72
    AMYT annual interest coverage ratio is 0.72

    Risk & Stability

    Piotroski F-Score

    2
    AMYT piotroski f-score is 2

    Altman Z-Score

    -
    AMYT altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jan 18, 23 HC Wainwright & Co.
    Neutral
    Jan 10, 23 Maxim Group
    Hold
    Jan 10, 23 Cantor Fitzgerald
    Neutral
    Jan 10, 23 Canaccord Genuity
    Hold
    Jan 9, 23 SVB Leerink
    Market Perform
    Jun 24, 22 SVB Leerink
    Outperform
    May 5, 22 SVB Leerink
    Outperform
    Mar 10, 22 SVB Leerink
    Outperform
    Mar 10, 22 HC Wainwright & Co.
    Buy
    Nov 23, 21 SVB Leerink
    Outperform

    Institutional Ownership

    Screeners with AMYT included

    No data
    • What is the ticker symbol for Amryt Pharma?
    • Does Amryt Pharma pay dividends?
    • What sector is Amryt Pharma in?
    • What industry is Amryt Pharma in?
    • What country is Amryt Pharma based in?
    • When did Amryt Pharma go public?
    • Is Amryt Pharma in the S&P 500?
    • Is Amryt Pharma in the NASDAQ 100?
    • Is Amryt Pharma in the Dow Jones?
    • When was Amryt Pharma's last earnings report?
    • When does Amryt Pharma report earnings?
    • Should I buy Amryt Pharma stock now?

    What is the ticker symbol for Amryt Pharma?

    The ticker symbol for Amryt Pharma is NASDAQ:AMYT

    Does Amryt Pharma pay dividends?

    No, Amryt Pharma does not pay dividends

    What sector is Amryt Pharma in?

    Amryt Pharma is in the Healthcare sector

    What industry is Amryt Pharma in?

    Amryt Pharma is in the Drug Manufacturers - Specialty & Generic industry

    What country is Amryt Pharma based in?

    Amryt Pharma is headquartered in Ireland

    When did Amryt Pharma go public?

    Amryt Pharma's initial public offering (IPO) was on July 8, 2020

    Is Amryt Pharma in the S&P 500?

    No, Amryt Pharma is not included in the S&P 500 index

    Is Amryt Pharma in the NASDAQ 100?

    No, Amryt Pharma is not included in the NASDAQ 100 index

    Is Amryt Pharma in the Dow Jones?

    No, Amryt Pharma is not included in the Dow Jones index

    When was Amryt Pharma's last earnings report?

    Amryt Pharma's most recent earnings report was on May 4, 2023

    When does Amryt Pharma report earnings?

    The date for Amryt Pharma's next earnings report has not been announced yet

    Should I buy Amryt Pharma stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page